STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

PATH VACCINE SOLUTIONS: Form 990, tax year 2017

View the entire original 990 at ProPublica ↗

Organization
PATH VACCINE SOLUTIONS (EIN 83-0431851)
Tax period
2017-01-01 to 2017-12-31
Filed
2018-11-12
IRS object ID
201803169349301940
Schema version
2017v2.3
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2018-11-12T13:07:00-06:00ReturnTs
Tax Period End2017-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN521392008PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1GELMAN ROSENBERG & FREEDMANBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line14550 MONTGOMERY AVE SUITE 650NAddressLine1Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP208142930ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2017-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN830431851EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1PATH VACCINE SOLUTIONSBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlPATHBusinessNameControlTxt
Phone2062853500PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVENUE NO 200AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98121ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonOLIVIA D POLIUSPersonNm
Person TitleCHIEF FINANCIAL OFFICERPersonTitleTxt
Phone2062853500PhoneNum
Signature2018-11-12SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Phone3019519090PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address75.103.231.202IPv4AddressTxt
FieldValueIRS element (for citing)
IP2018-11-12IPDt
IP Tm14:06:56IPTm
IP TimezoneESIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device Id4FA38BE9C690C82C721A5060F87FC7588CB81F81AtSubmissionCreationDeviceId
At Submission Filing Device Id92DED79A3FD2BE8CA1FF310A7D004DEBEF0EEB01AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2017TaxYr
Build TS2019-02-21 02:37:17ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerOLIVIA D POLIUSPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVENUE NO 200AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98121ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$33,220,750GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.PATH.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2006FormationYr
Legal Domicile StateWALegalDomicileStateCd
Activity Or MissionSEE PART III, LINE 1.ActivityOrMissionDesc
Voting Members Governing Body7VotingMembersGoverningBodyCnt
Voting Members Independent2VotingMembersIndependentCnt
Total Employee0TotalEmployeeCnt
Total Volunteers0TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$4,727,165PYContributionsGrantsAmt
CY Contributions Grants$6,592,045CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$1,239,778PYInvestmentIncomeAmt
CY Investment Income$504,329CYInvestmentIncomeAmt
PY Other Revenue$23,560PYOtherRevenueAmt
CY Other Revenue$12,542CYOtherRevenueAmt
PY Total Revenue$5,990,503PYTotalRevenueAmt
CY Total Revenue$7,108,916CYTotalRevenueAmt
PY Grants And Similar Paid$29,855,678PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$30,367,803CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$0PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$0CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$12,217,095PYOtherExpensesAmt
CY Other Expenses$13,366,543CYOtherExpensesAmt
PY Total Expenses$42,072,773PYTotalExpensesAmt
CY Total Expenses$43,734,346CYTotalExpensesAmt
PY Revenues Less Expenses-$36,082,270PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$36,625,430CYRevenuesLessExpensesAmt
Total Assets BOY$107,465,507TotalAssetsBOYAmt
Total Assets EOY$66,391,789TotalAssetsEOYAmt
Total Liabilities BOY$15,803,401TotalLiabilitiesBOYAmt
Total Liabilities EOY$14,042,965TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$91,662,106NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$52,348,824NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE MISSION OF PATH VACCINE SOLUTIONS (PVS) IS TO IMPROVE THE HEALTH OF CHILDREN IN LOW-INCOME COUNTRIES BY ACCELERATING THE DEVELOPMENT OF VACCINES THAT WILL BE EFFECTIVE AND AFFORDABLE FOR THOSE WHO NEED THEM MOST.FROM INITIAL DISCOVERY THROUGH CLINICAL TRIALS, PVS WORKS WITH COMMERCIAL PARTNERS, SUCH AS VACCINE MANUFACTURERS AND BIOTECHNOLOGY FIRMS, AND NONPROFIT PARTNERS, SUCH AS UNIVERSITIES AND RESEARCH INSTITUTIONS, TO SHORTEN THE TIMELINE FOR VACCINE DEVELOPMENT.PVS WORKS WITH PARTNERS TO DEVELOP NEW VACCINES BY PROVIDING FUNDING AND EXPERTISE IN PRECLINICAL DEVELOPMENT, MANUFACTURING, AND CLINICAL DEVELOPMENT, WITH A FOCUS ON LOW-RESOURCE COUNTRIES. IN RETURN, PARTNERS AGREE TO TERMS THAT HELP ENSURE THE RESULTING PRODUCTS ARE AFFORDABLE AND AVAILABLE IN DEVELOPING COUNTRIES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$43,734,346ExpenseAmt
Grant$30,367,803GrantAmt
DescPVS WORKS TO PREVENT DEATH AND DISEASE CAUSED BY DIARRHEA, PNEUMONIA, INFLUENZA, RESPIRATORY SYNCYTIAL VIRUS, AND POLIO AMONG CHILDREN AROUND THE WORLD. WE ACCELERATE THE DEVELOPMENT OF SAFE, EFFICACIOUS, AND AFFORDABLE VACCINES IN PARTNERSHIP WITH PUBLIC AND PRIVATE GROUPS. IN 2017, PVS CONTINUED OUR FIGHT AGAINST DIARRHEAL DISEASES, THE SECOND LEADING CAUSE OF DEATH AMONG CHILDREN IN LOW-INCOME COUNTRIES. TO COMBAT ROTAVIRUS, A MAJOR CAUSE OF SEVERE DIARRHEA, WE CONTINUED CLINICAL DEVELOPMENT OF A NONREPLICATING ROTAVIRUS VACCINE CANDIDATE. THIS TYPE OF ROTAVIRUS VACCINE WOULD BE ADMINISTERED AS AN INTRAMUSCULAR INJECTION AND COULD POTENTIALLY OVERCOME THE LOWER EFFICACY LEVELS SEEN IN LOW-RESOURCE SETTINGS FOR ORAL, LIVE, ATTENUATED VACCINES. WE ALSO COMPLETED A STUDY WITH SERUM INSTITUTE OF INDIA PVT. LTD. (SIIPL) OF A ROTAVIRUS VACCINE ABLE TO REMAIN STABLE AND POTENT DURING EXTENDED PERIODS WITHOUT REFRIGERATION, ENABLING WIDER USE IN REMOTE COMMUNITIES. IN SEPTEMBER 2017, THE GOVERNMENT OF INDIA ORDERED SIIPL'S VACCINE, ROTASIIL, FOR USE IN THE COUNTRY'S UNIVERSAL IMMUNIZATION PROGRAM. IN ADDITION, ROTAVAC, ANOTHER INDIAN-MADE VACCINE DEVELOPED WITH PATH SUPPORT, ADVANCED TOWARD WORLD HEALTH ORGANIZATION PREQUALIFICATION. WE CONTINUED TO CONDUCT EARLY-STAGE CLINICAL TRIALS OF VACCINE CANDIDATES THAT MAY PROVIDE PROTECTION AGAINST ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) AND SHIGELLA, LEADING CAUSES OF BACTERIAL DIARRHEAL ILLNESS. CURRENTLY, THERE ARE NO LICENSED VACCINES AGAINST EITHER PATHOGEN. WE ALSO ADVANCED DEVELOPMENT OF LOW-COST VACCINE CANDIDATES TO PROTECT CHILDREN AGAINST PNEUMOCOCCAL BACTERIA, THE TOP CAUSE OF SEVERE CHILDHOOD PNEUMONIA. IN 2017, WE BEGAN A PHASE 3 STUDY IN THE GAMBIA TO EVALUATE A PNEUMOCOCCAL CONJUGATE VACCINE (PCV-10) CANDIDATE DESIGNED TO BE AFFORDABLE AND TO PROVIDE PROTECTION AGAINST TEN BACTERIAL SEROTYPES THAT CAUSE MOST CASES OF INVASIVE PNEUMOCOCCAL DISEASE IN AFRICA AND ASIA. IN KENYA, WE STUDIED A VACCINE CANDIDATE WITH THE POTENTIAL TO PROVIDE LOW-COST, BROAD PROTECTION ACROSS MANY SEROTYPES.Desc
Total Program Service Expenses$43,734,346TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign OfficeYes (1)ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document0IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee0EmployeeCnt
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members7GoverningBodyVotingMembersCnt
Independent Voting Member2IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEO0CompensationProcessCEOInd
Compensation Process Other0CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1OLIVIA POLIUS CHIEF FINANCIAL OFFICERBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone2062853500PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVE SUITE 200AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98121ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (7 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
STEPHEN B DAVIS
CHAIR AND PRESIDENT1.0039.00Yes (X)Yes (X)$0$641,522$65,784
PENNY HEATON
VICE CHAIR1.000.00Yes (X)Yes (X)$0$0$0
OLIVIA D POLIUS
TREASURER1.0039.00Yes (X)Yes (X)$0$311,327$53,104
DANIEL LASTER
SECRETARY1.0039.00Yes (X)Yes (X)$0$334,058$41,018
AMIE E BATSON
DIRECTOR1.0039.00Yes (X)$0$312,831$27,395
DAVID C KASLOW
DIRECTOR1.0039.00Yes (X)$0$368,007$67,708
CHRIS KARP
DIRECTOR1.000.00Yes (X)$0$0$0
FieldValueIRS element (for citing)
Total Reportable Comp From Org$0TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$1,967,745TotReportableCompRltdOrgAmt
Total Other Compensation$255,009TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K0IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
All Other Contributions$6,592,045AllOtherContributionsAmt
Total Contributions$6,592,045TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$646,343TotalRevenueColumnAmt
Exclusion$646,343ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$25,969,820SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$26,111,834SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$142,014SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$142,014TotalRevenueColumnAmt
Exclusion-$142,014ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescOTHER REIMBURSEMENTSDesc
Business900099BusinessCd
Total Revenue Column$12,542TotalRevenueColumnAmt
Exclusion$12,542ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$12,542OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$7,108,916TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$516,871ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$23,543,484TotalAmt
Program Services$23,543,484ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$6,824,319TotalAmt
Program Services$6,824,319ProgramServicesAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$6,246TotalAmt
Program Services$6,246ProgramServicesAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$1,664TotalAmt
Program Services$1,664ProgramServicesAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$40,554TotalAmt
Program Services$40,554ProgramServicesAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$381,903TotalAmt
Program Services$381,903ProgramServicesAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$4,433TotalAmt
Program Services$4,433ProgramServicesAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$236,297TotalAmt
Program Services$236,297ProgramServicesAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$34,168TotalAmt
Program Services$34,168ProgramServicesAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$2,500TotalAmt
Program Services$2,500ProgramServicesAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,193,427TotalAmt
Program Services$1,193,427ProgramServicesAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$88,630TotalAmt
Program Services$88,630ProgramServicesAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$45,152TotalAmt
Program Services$45,152ProgramServicesAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$37,525TotalAmt
Program Services$37,525ProgramServicesAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmt
SUBCONTRACTORS$10,885,797$10,885,797
LAB SUPPLIES$235,358$235,358
STORAGE$85,469$85,469
EQUIPMENT R&M$79,561$79,561

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$7,859TotalAmt
Program Services$7,859ProgramServicesAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$43,734,346TotalAmt
Program Services$43,734,346ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$32,558,748BOYAmt
EOY$21,866,566EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$202,886BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$70BOYAmt
EOY$56,033EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$261,010LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$236,662LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$42,765BOYAmt
EOY$24,348EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$74,661,038BOYAmt
EOY$44,444,842EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$107,465,507BOYAmt
EOY$66,391,789EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$15,803,401BOYAmt
EOY$14,042,965EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$15,803,401BOYAmt
EOY$14,042,965EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$18,107BOYAmt
EOY$8,544EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$91,643,999BOYAmt
EOY$52,340,280EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$91,662,106BOYAmt
EOY$52,348,824EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$107,465,507BOYAmt
EOY$66,391,789EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$36,625,430ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$86,322NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets-$2,774,174OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Supporting Organization509a3Yes (X)SupportingOrganization509a3Ind
Supporting Org Type1Yes (X)SupportingOrgType1Ind
Supported Organizations1SupportedOrganizationsCnt

Supported Org Information SupportedOrgInformationGrp

Supported Organization Name SupportedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1PATHBusinessNameLine1Txt
FieldValueIRS element (for citing)
EIN911157127EIN
Organization Type7OrganizationTypeCd
Governing Document ListedYes (1)GoverningDocumentListedInd
Support$43,734,346SupportAmt
Other Support$0OtherSupportAmt
FieldValueIRS element (for citing)
Supported Organizations Total1SupportedOrganizationsTotalCnt
Support Sum$43,734,346SupportSumAmt
Other Support Sum$0OtherSupportSumAmt

Form990 Sch A Supporting Org Form990SchASupportingOrgGrp

FieldValueIRS element (for citing)
Listed By Name Governing DocYes (1)ListedByNameGoverningDocInd
Suprt Org No IRS Determination0SuprtOrgNoIRSDeterminationInd
Supported Org Section C4560SupportedOrgSectionC456Ind
Supported Org Not Organized US0SupportedOrgNotOrganizedUSInd
Organization Change Suprt Org0OrganizationChangeSuprtOrgInd
Support Non Supported Org0SupportNonSupportedOrgInd
Payment Substantial Contribtr0PaymentSubstantialContribtrInd
Loan Disqualified Person0LoanDisqualifiedPersonInd
Controlled Disqualified Prsn0ControlledDisqualifiedPrsnInd
Disqualified Prsn Controll Int0DisqualifiedPrsnControllIntInd
Disqualified Prsn Ownr Int0DisqualifiedPrsnOwnrIntInd
Excess Business Holdings Rules0ExcessBusinessHoldingsRulesInd
Contribution Controller0ContributionControllerInd
Contribution Family0ContributionFamilyInd
Contribution35 Controlled0Contribution35ControlledInd

Form990 Sch A Type1 Suprt Org Form990SchAType1SuprtOrgGrp

FieldValueIRS element (for citing)
Power Appoint Majority Dir TrstYes (1)PowerAppointMajorityDirTrstInd
Operate Benefit Non Suprt Org0OperateBenefitNonSuprtOrgInd

Schedule B IRS990ScheduleB

Schedule D IRS990ScheduleD

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$261,010OtherCostOrOtherBasisAmt
Depreciation$236,662DepreciationAmt
Book Value$24,348BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$24,348TotalBookValueLandBuildingsAmt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (11 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EAST ASIA AND THE PACIFIC00PROGRAM SERVICESESSENTIAL MEDICINE$136,360
EAST ASIA AND THE PACIFIC00GRANTMAKING$232,554
EUROPE00PROGRAM SERVICESESSENTIAL MEDICINE$573,248
EUROPE00GRANTMAKING$4,535,641
NORTH AMERICA00PROGRAM SERVICESESSENTIAL MEDICINE$15,192
SOUTH AMERICA00PROGRAM SERVICESESSENTIAL MEDICINE$7,589
SOUTH ASIA05PROGRAM SERVICESESSENTIAL MEDICINE$1,062,217
SOUTH ASIA00GRANTMAKING$1,422,862
SUB-SAHARAN AFRICA01PROGRAM SERVICESESSENTIAL MEDICINE$755,150
SUB-SAHARAN AFRICA00GRANTMAKING$633,262
MIDDLE EAST AND NORTH AFRICA00PROGRAM SERVICESESSENTIAL MEDICINE$1,699
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees5SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee1ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee6TotalEmployeeCnt
Subtotal Spent$7,985,663SubtotalSpentAmt
Continuation Spent$1,390,111ContinuationSpentAmt
Total Spent$9,375,774TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (23 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
SOUTH ASIAESSENTIAL MEDICINE$318,406CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE$5,161CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE$908,727CHECK/WIRE
EAST ASIA & THE PACIFICESSENTIAL MEDICINE$180,469CHECK/WIRE
EUROPEESSENTIAL MEDICINE$97,929CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE$463,425CHECK/WIRE
EUROPEESSENTIAL MEDICINE$242,865CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE$20,619CHECK/WIRE
EUROPEESSENTIAL MEDICINE$1,402,243CHECK/WIRE
EAST ASIA & THE PACIFICESSENTIAL MEDICINE$52,085CHECK/WIRE
EUROPEESSENTIAL MEDICINE$74,902CHECK/WIRE
EUROPEESSENTIAL MEDICINE$2,235,000CHECK/WIRE
SUB-SAHARAN AFRICAESSENTIAL MEDICINE$265,851CHECK/WIRE
EUROPEESSENTIAL MEDICINE$59,816CHECK/WIRE
EUROPEESSENTIAL MEDICINE$200,000CHECK/WIRE
EUROPEESSENTIAL MEDICINE$50,000CHECK/WIRE
EUROPEESSENTIAL MEDICINE$26,118CHECK/WIRE
SUB-SAHARAN AFRICAESSENTIAL MEDICINE$142,190CHECK/WIRE
SUB-SAHARAN AFRICAESSENTIAL MEDICINE$225,221CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE-$247,717CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE-$32,963CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE-$12,796CHECK/WIRE
EUROPEESSENTIAL MEDICINE$146,769CHECK/WIRE
FieldValueIRS element (for citing)
Total501c3 Org19Total501c3OrgCnt
Total Other Org4TotalOtherOrgCnt
Transfer To Foreign CorpYes (1)TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationPVS PERFORMS RISK-BASED MONITORING OF SUBRECIPIENTS. POLICIES AND PROCEDURES ARE IN PLACE TO GUIDE PROJECT TEAMS' FINANCIAL AND TECHNICAL MONITORING OF SUBRECIPIENTS. TO PROVIDE THE MONITORING REQUIRED BY FUNDERS AND TO ENSURE GOOD STEWARDSHIP OF EVERY PROJECT, PVS USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, OR OTHER MEANS TO PROVIDE RESPONSIBLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS AND THAT IT ACHIEVES PERFORMANCE GOALS.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (21 entries)

Address Line1USAddress/AddressLine1TxtAddress Line2USAddress/AddressLine2TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
ADVANCED BIOSCIENCE LABORATORIES INC
9800 MEDICAL CENTER DRIVE BUILDINGDROCKVILLEMD20850621242262N/A$1,148,163PRODUCT DEVELOPMENT
BOSTON CHILDREN'S HOSPITAL
300 LONGWOOD AVENUEBOSTONMA02115042774441501(C)(3)$340,000PRODUCT DEVELOPMENT
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
ACCOUNTING DEPARTMENT MLC 4900 3333BURNECINCINNATIOH45229310833936501(C)(3)$882,368PRODUCT DEVELOPMENT
FAMILY HEALTH INTERNATIONAL 360
FHI 360 HEADQUARTERS 359 BLACKWELLST SUITE 200DURHAMNC27701237413005501(C)(3)$31,230PRODUCT DEVELOPMENT
FOOD & DRUG ADMINISTRATION
10903 NEW HAMPSHIRE AVENUESILVER SPRINGMD20993530196965GOV$80,000PRODUCT DEVELOPMENT
HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE
4301 JONES BRIDGE ROAD ROOM G074BETHESDAMD20814521317896501(C)(3)$497,310PRODUCT DEVELOPMENT
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1428 MADISON AVENUENEW YORKNY10029136171197501(C)(3)$224,000PRODUCT DEVELOPMENT
IMMPORT THERAPEUTICS INC
1 TECHNOLOGY DRIVE SUITE E309IRVINECA92618050543092N/A$234,526PRODUCT DEVELOPMENT
INFECTIOUS DISEASE RESEARCH INSTITUTE
1616 EASTLAKE AVE E SUITE 400SEATTLEWA98102911608978501(C)(3)$1,343,203PRODUCT DEVELOPMENT
JHU BLOOMBERG SCHOOL OF PUBLIC HEALTH
615 N WOLFE STREETBALTIMOREMD21205131687001501(C)(3)$225,584PRODUCT DEVELOPMENT
JOHNS HOPKINS UNIVERSITY
OFFICE OF RESEARCH ADMIN 615 NWOLFE STREET W1100BALTIMOREMD21205131687001501(C)(3)$326,104PRODUCT DEVELOPMENT
KANSAS STATE UNIVERSITY
2 FAIRCHILD HALL DEPT OF GRAINSCIENCE INDUSTRYMANHATTANKS66506480771751501(C)(3)$169,560PRODUCT DEVELOPMENT
LANKENAU INSTITUTE FOR MEDICAL RESEARCH
100 E LANCASTER AVEWYNNEWOODPA190963450232175659501(C)(3)$81,668PRODUCT DEVELOPMENT
TULANE EDUCATIONAL FUND
1430 TULANE AVENUE TB-32NEW ORLEANSLA701122632720423889501(C)(3)$58,060PRODUCT DEVELOPMENT
UNITED STATES NAVAL MEDICAL RESEARCH CENTER
503 ROBERT GRANT AVESILVER SPRINGMD209107500470100048GOV$858,868PRODUCT DEVELOPMENT
UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC
2385 IRVING HILL ROADLAWRENCEKS66045480680117501(C)(3)$18,000PRODUCT DEVELOPMENT
UNIVERSITY OF MARYLAND BALTIMORE
PO BOX 41428BALTIMOREMD212036428526002033501(C)(3)$265,356PRODUCT DEVELOPMENT
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE CENTER FOR VACCINE DEVELOPMENT
685 WEST BALTIMORE STREETBALTIMOREMD21201526002033501(C)(3)$873,058PRODUCT DEVELOPMENT
WALTER REED ARMY INSTITUTE OF RESEARCH
503 ROBERT GRANT AVENUESILVER SPRINGMD209107500520664528GOV$590,550PRODUCT DEVELOPMENT
BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA
701 20TH STREET SOUTH AB 1170BIRMINGHAMAL352940111636001138501(C)(3)-$16,482PRODUCT DEVELOPMENT
PATH
2201 WESTLAKE AVE SUITE 200SEATTLEWA98121911157127501(C)(3)$15,312,358PRODUCT DEVELOPMENT
FieldValueIRS element (for citing)
Total501c3 Org19Total501c3OrgCnt
Total Other Org2TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationPVS PERFORMS RISK-BASED MONITORING OF SUBRECIPIENTS. POLICIES AND PROCEDURES ARE IN PLACE TO GUIDE PROJECT TEAMS' FINANCIAL AND TECHNICAL MONITORING OF SUBRECIPIENTS. TO PROVIDE THE MONITORING REQUIRED BY FUNDERS AND TO ENSURE GOOD STEWARDSHIP OF EVERY PROJECT, PVS USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, OR OTHER MEANS TO PROVIDE RESPONSIBLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS AND THAT IT ACHIEVES PERFORMANCE GOALS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (5 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
STEPHEN B DAVIS
CHAIR AND PRESIDENT$0$486,134$0$147,638$0$7,750$0$32,200$0$33,584$0$707,306$0$0
OLIVIA D POLIUS
TREASURER$0$309,227$0$0$0$2,100$0$32,400$0$20,704$0$364,431$0$0
DANIEL LASTER
SECRETARY$0$332,258$0$0$0$1,800$0$32,400$0$8,618$0$375,076$0$0
AMIE E BATSON
DIRECTOR$0$301,024$0$0$0$11,807$0$26,579$0$816$0$340,226$0$0
DAVID C KASLOW
DIRECTOR$0$358,097$0$0$0$9,910$0$32,400$0$35,308$0$435,715$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 3FormAndLineReferenceDesc
ExplanationPVS RELIES ON A RELATED ORGANIZATION, PATH, TO DETERMINE COMPENSATION. PATH USES THE FOLLOWING TO ESTABLISH COMPENSATION OF THE EXECUTIVE DIRECTOR: - COMPENSATION COMMITTEE - INDEPENDENT COMPENSATION CONSULTANT - COMPENSATION SURVEY OR STUDY - APPROVAL BY THE BOARD OR COMPENSATION COMMITTEEExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 WAS PREPARED BY AN OUTSIDE ACCOUNTING FIRM (GELMAN, ROSENBERG & FREEDMAN, CPAS), USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE DRAFT WAS SENT TO PVS'S BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE CHIEF FINANCIAL OFFICER SIGNED AND FILED THE RETURN.
FORM 990, PART VI, SECTION B, LINE 12CPVS HAS A WRITTEN CONFLICT OF INTEREST POLICY UNDER WHICH ALL PVS BOARD MEMBERS AND OFFICERS MUST ANNUALLY COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM. PVS DOES NOT HAVE EMPLOYEES. PVS IS A SUPPORTING ORGANIZATION TO PATH WITHIN THE MEANING OF INTERNAL REVENUE CODE SECTION 509(A)(3) AND CONTRACTS WITH PATH FOR MANAGEMENT SERVICES. PATH HAS A WRITTEN CONFLICT OF INTEREST POLICY UNDER WHICH ALL PATH BOARD MEMBERS, OFFICERS, AND STAFF AT HIGHER THAN A DESIGNATED LEVEL MUST ANNUALLY COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM. ALL PVS AND PATH DISCLOSURE FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. PATH ALSO HAS A WELL-DEFINED PROCEDURE FOR IDENTIFYING AND REPORTING ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AMONG BOARD MEMBERS. NEW BOARD MEMBERS ARE ASKED TO COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM WITHIN 30 DAYS OF JOINING THE BOARD AND TO COMPLETE A NEW FORM ANNUALLY THEREAFTER. IN ADDITION, MEMBERS ARE REMINDED TO REPORT ANY NEW ISSUES THAT ARISE OUTSIDE OF THE ANNUAL DISCLOSURE PERIOD. THE DISCLOSURE FORMS ARE REVIEWED BY PATH'S GENERAL COUNSEL, AND IF ANY ACTUAL OR POTENTIAL CONFLICTS ARE IDENTIFIED, GENERAL COUNSEL MAKES A RECOMMENDATION TO THE CHAIR OF THE GOVERNANCE COMMITTEE AND THE CHAIR OF THE BOARD FOR A MANAGEMENT PLAN TO PROPERLY MANAGE ANY CONFLICTS. A FORMAL MANAGEMENT PLAN IS THEN AGREED UPON WITH THE BOARD MEMBER, AND THE ENTIRE BOARD OF DIRECTORS IS INFORMED AT THE NEXT REGULARLY SCHEDULED BOARD MEETING.
FORM 990, PART VI, SECTION C, LINE 19PVS'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST; MOST DOCUMENTS ARE ALSO AVAILABLE ONLINE.
FORM 990, PART XI, LINE 9:FROM TIME TO TIME, UNSPENT AWARD FUNDS (OR UNUSED OBLIGATIONS) MAY BE RETURNED TO A FUNDER FOR A VARIETY OF REASONS INCLUDING, BUT NOT LIMITED TO, EARLY TERMINATION OF A PROJECT BY A FUNDER OR A REDUCTION IN FUNDS REQUIRED TO ACCOMPLISH A PROJECT'S SCOPE OF WORK. -2,774,174.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtPublic Charity StatusPublicCharityStatusTxtDirect Controlling NADirectControllingNACdControlled OrganizationControlledOrganizationIndBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmCountryForeignAddress/CountryCdLegal Domicile Foreign CountryLegalDomicileForeignCountryCd
PATH
2201 WESTLAKE AVE SUITE 200SEATTLEWA98121911157127GLOBAL HEALTHWA501(C)(3)LINE 7N/A0
PATH DRUG SOLUTIONS
600 CALIFORNIA STREET SUITE 14-001SAN FRANCISCOCA94108943384500DEVELOPMENT & DISTRIBUTION OF SAFE, EFFECTIVE, AND AFFORDABLE MEDICINESCA501(C)(3)LINE 12A, IYes (1)PATH
FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND
EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH501(C)(3)Yes (1)PATHRUE DE VAREMBE 7GENEVASZSZ
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgYes (1)GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd